Clinical trial
Evaluation of Beta-amyloid Plaques of the Retina Using Metabolic Hyperspectral Retinal Camera (MHRC) in Alzheimer's Patients - Toronto Study Arm
NCT03420807 is registered in ClinicalTrials.gov with Optina Diagnostics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Beta-amyloid Plaques of the Retina Using Metabolic Hyperspectral Retinal Camera (MHRC) in Alzheimer's Patients - Toronto Study Arm
- Lead sponsor
- Optina Diagnostics Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 4, 2017
- Completion date
- March 12, 2020
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.